Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis.

Cancer epidemiology - 1 Dec 2011

Dahabreh Issa J, Murray Samuel

Abstract excerpt

BACKGROUND: Multiple epidemiological studies have investigated rs1136201, a non-synonymous polymorphism of the human epidermal growth factor receptor-2 gene (HER2) resulting in the substitution of valine for isoleucine at codon 655 (Ile655Val) of the HER2 protein, as a risk factor for breast cancer. METHODS: We searched multiple databases to identify genetic association studies investigating the effect of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, erbB-2

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Odds Ratio

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Source

Identifiers

PMID: 21474413
DOI: 10.1016/j.canep.2011.01.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis.PMID 21474413Read ↗

Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects.Semantic proximity Read ↗

Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study.Semantic proximity Read ↗

ERBB2 genetic polymorphism and breast cancer risk in Chinese women: a population-based case-control study.Semantic proximity Read ↗

Human Epidermal Growth Factor Receptor-2 gene polymorphism and breast cancer risk in women from the Northeastern region of Brazil.Semantic proximity Read ↗

HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies.Semantic proximity Read ↗

Vascular endothelial growth factor gene polymorphism (-634G/C) and breast cancer risk.Semantic proximity Read ↗

Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects.Semantic proximity Read ↗

A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer.Semantic proximity Read ↗

The polymorphism of EGFR 142285G > A exerts no risk effect on breast cancer.Semantic proximity Read ↗

Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.Semantic proximity Read ↗

Lack of association of the cyclooxygenase-2 gene 8473T>C polymorphism with breast cancer risk: a meta-analysis.Semantic proximity Read ↗

Lack of association between insulin receptor substrate2 rs1805097 polymorphism and the risk of colorectal and breast cancer: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.